Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock - Seite 3 Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced the pricing of an underwritten offering of …